Literature DB >> 20091875

Polysaccharide-modified synthetic polymeric biomaterials.

Aaron D Baldwin1, Kristi L Kiick.   

Abstract

This review presents an overview of <span class="Chemical">polysaccharide-conjugated synthetic polymers and their use in tissue-engineered scaffolds and drug-delivery applications. This topic will be divided into four categories: (1) polymeric materials modified with non-mammalian polysaccharides such as alginate, chitin, and dextran; (2) polymers modified with mammalian polysaccharides such as hyaluronan, chondroitin sulfate, and heparin; (3) multi-polysaccharide-derivatized polymer conjugate systems; and (4) polymers containing polysaccharide-mimetic molecules. Each section will discuss relevant conjugation techniques, analysis, and the impact of these materials as micelles, particles, or hydrogels used in in-vitro and in-vivo biomaterial applications. (c) 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20091875      PMCID: PMC2900782          DOI: 10.1002/bip.21334

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  136 in total

1.  Hyaluronan: Preparation, Structure, Properties, and Applications.

Authors:  Lubomír Lapcík; Stefaan De Smedt; Joseph Demeester; Peter Chabrecek
Journal:  Chem Rev       Date:  1998-12-17       Impact factor: 60.622

Review 2.  Implantable applications of chitin and chitosan.

Authors:  Eugene Khor; Lee Yong Lim
Journal:  Biomaterials       Date:  2003-06       Impact factor: 12.479

3.  Experimental Observations on Absorbable Alginate Products in Surgery : Gel, Film, Gauze and Foam.

Authors:  G Blaine
Journal:  Ann Surg       Date:  1947-01       Impact factor: 12.969

4.  VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase.

Authors:  Christopher J Robinson; Barbara Mulloy; John T Gallagher; Sally E Stringer
Journal:  J Biol Chem       Date:  2005-10-28       Impact factor: 5.157

5.  Discovery of a sulfated tetrapeptide that binds to vascular endothelial growth factor.

Authors:  Heather D Maynard; Jeffrey A Hubbell
Journal:  Acta Biomater       Date:  2005-06-13       Impact factor: 8.947

6.  Action of microparticles of heparin and alginate crosslinked gel when used as injectable artificial matrices to stabilize basic fibroblast growth factor and induce angiogenesis by controlling its release.

Authors:  Naofumi Chinen; Masao Tanihara; Miyako Nakagawa; Keiko Shinozaki; Eriko Yamamoto; Yutaka Mizushima; Yasuo Suzuki
Journal:  J Biomed Mater Res A       Date:  2003-10-01       Impact factor: 4.396

Review 7.  Heparin and heparan sulfate: structure and function.

Authors:  Dallas L Rabenstein
Journal:  Nat Prod Rep       Date:  2002-06       Impact factor: 13.423

8.  Synthesis and characterization of partially biodegradable and thermosensitive hydrogel.

Authors:  Xian-Zheng Zhang; Guo-Ming Sun; Da-Qing Wu; Chih-Chang Chu
Journal:  J Mater Sci Mater Med       Date:  2004-08       Impact factor: 3.896

9.  Production of heparin-containing hydrogels for modulating cell responses.

Authors:  Ting Nie; Robert E Akins; Kristi L Kiick
Journal:  Acta Biomater       Date:  2008-12-24       Impact factor: 8.947

10.  Synthesis and characterization of a chondroitin sulfate-polyethylene glycol corneal adhesive.

Authors:  Iossif Strehin; Winnette McIntosh Ambrose; Oliver Schein; Afrah Salahuddin; Jennifer Elisseeff
Journal:  J Cataract Refract Surg       Date:  2009-03       Impact factor: 3.351

View more
  38 in total

1.  Therapeutic effect of orally administered microencapsulated oxaliplatin for colorectal cancer.

Authors:  Aleksandra M Urbanska; Emmanouil D Karagiannis; Gonzalo Guajardo; Robert S Langer; Daniel G Anderson
Journal:  Biomaterials       Date:  2012-04-01       Impact factor: 12.479

2.  Imaging of homeostatic, neoplastic, and injured tissues by HA-based probes.

Authors:  Mandana Veiseh; Daniel Breadner; Jenny Ma; Natalia Akentieva; Rashmin C Savani; Rene Harrison; David Mikilus; Lisa Collis; Stefan Gustafson; Ting-Yim Lee; James Koropatnick; Leonard G Luyt; Mina J Bissell; Eva A Turley
Journal:  Biomacromolecules       Date:  2011-12-12       Impact factor: 6.988

Review 3.  Leveraging "raw materials" as building blocks and bioactive signals in regenerative medicine.

Authors:  Amanda N Renth; Michael S Detamore
Journal:  Tissue Eng Part B Rev       Date:  2012-05-21       Impact factor: 6.389

4.  A bioactive self-assembled membrane to promote angiogenesis.

Authors:  Lesley W Chow; Ronit Bitton; Matthew J Webber; Daniel Carvajal; Kenneth R Shull; Arun K Sharma; Samuel I Stupp
Journal:  Biomaterials       Date:  2010-11-18       Impact factor: 12.479

5.  In situ crosslinkable heparin-containing poly(ethylene glycol) hydrogels for sustained anticoagulant release.

Authors:  Aaron D Baldwin; Karyn G Robinson; Jaimee L Militar; Christopher D Derby; Kristi L Kiick; Robert E Akins
Journal:  J Biomed Mater Res A       Date:  2012-05-21       Impact factor: 4.396

Review 6.  Polymeric materials for theranostic applications.

Authors:  Zhe Wang; Gang Niu; Xiaoyuan Chen
Journal:  Pharm Res       Date:  2013-06-14       Impact factor: 4.200

7.  The crosslinking of polysaccharides with polyamines and dextran-polyallylamine antibacterial hydrogels.

Authors:  Naphtali A O'Connor; Ahmad Abugharbieh; Farzana Yasmeen; Emmanuel Buabeng; Steve Mathew; Diana Samaroo; Hai-Ping Cheng
Journal:  Int J Biol Macromol       Date:  2014-08-13       Impact factor: 6.953

Review 8.  Tuning the biomimetic behavior of scaffolds for regenerative medicine through surface modifications.

Authors:  Nathan R Richbourg; Nicholas A Peppas; Vassilios I Sikavitsas
Journal:  J Tissue Eng Regen Med       Date:  2019-06-25       Impact factor: 3.963

Review 9.  Application of polysaccharides for surface modification of nanomedicines.

Authors:  Kyung-Oh Doh; Yoon Yeo
Journal:  Ther Deliv       Date:  2012-12

10.  Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors.

Authors:  Tyrel T Smith; Howell F Moffett; Sirkka B Stephan; Cary F Opel; Amy G Dumigan; Xiuyun Jiang; Venu G Pillarisetty; Smitha P S Pillai; K Dane Wittrup; Matthias T Stephan
Journal:  J Clin Invest       Date:  2017-04-24       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.